ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Inovalon Launches SDOH Market Insights SaaS Solution For Life Sciences To Elevate Health Equity Driven Engagement

BOWIE, Md., April 11, 2024 (GLOBE NEWSWIRE) -- Inovalon, a leading provider of cloud-based software solutions empowering data-driven healthcare, today launched SDOH Market Insights to help life sciences organizations make data-driven decisions to address disparities in health outcomes and access. This new SaaS solution delivers advanced data visualizations and analytics that identify social risk factors and how they impact healthcare utilization and quality within specific populations. SDOH Market Insights is built on Inovalon’s MORE² Registry®, the industry’s leading, primary source patient dataset. This solution integrates patient demographic, clinical, geospatial, and social drivers of health (SDOH) data to inform strategies intended to overcome access barriers, optimize engagement, and achieve more equitable and better care at lower costs.

The healthcare and life sciences community has long understood the powerful effect social and economic factors — such as income, language proficiency, and access to transportation — can have on health outcomes. Studies indicate that these factors contribute up to 80% of health outcomes, and Inovalon’s research demonstrates that health disparities can impact certain populations differently, so the lack of comprehensive and actionable SDOH data makes it challenging to benchmark and improve performance. SDOH Market Insights provides a comprehensive understanding of how SDOH impacts patients and healthcare by characterizing population profiles and focusing on geographic areas of interest to help guide personalized interventions, quality improvements, resource utilization, medication adherence, value-based care, clinical trial recruitment, and optimization.

"Achieving health equity simply isn't possible without a complete view of how social drivers of health impact populations," said John Chinnici, President and General Manager of Insights at Inovalon. "For example, only about half of Americans adhere to prescribed chronic medications. Social drivers can exacerbate nonadherence when life sciences and providers are not working together to make data-driven interventions. We created SDOH Market Insights using our rich primary source data to align a broad range of stakeholders and equip them with insights they need to materially improve resource allocation, cost-effectiveness, and health outcomes for all."

SDOH Market Insights adheres to strict data privacy regulations and provides access to more than 50 distinct types of social drivers of health data, as well as actionable national and sub-national visualizations. Inovalon's MORE² Registry® fuels SDOH Market Insights with advanced analytic capabilities and comprehensive and representative data on 169 million U.S. lives annually.

To learn more about SDOH Market Insights, please visit inovalon.com/sdoh-market-insights.

About Inovalon

Inovalon is a leading provider of cloud-based SaaS solutions empowering data-driven healthcare. The Inovalon ONE® Platform brings together national-scale connectivity, real-time primary source data access, and advanced analytics into a sophisticated cloud-based platform empowering improved outcomes and economics across the healthcare ecosystem. The company’s analytics and capabilities are used by nearly 20,000 customers supporting over 53,000 sites of care, and are informed by the primary source data of more than 82 billion medical events across 1.1 million physicians, 665,000 clinical settings, and 384 million unique lives. For more information, visit www.inovalon.com.

Contact:
Tom Paolella
Sr. Director, Press and Analyst Relations, Inovalon
Thomas.Paolella@inovalon.com


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.